25 September 2015

Pharmaceutical businessmen are far from oilmen, but still…

23 pharmaceutical companies entered the RBC 500 rating


It follows from it that the leading positions in the economy are occupied by oil companies. The revenue of the list participants is equal to almost 80% of the country's GDP.

The revenue of the 500 largest Russian companies in 2014 exceeded 56 trillion rubles – the equivalent of about 77% of Russia's GDP in the same year. At least 7.5 million people work in RBC 500 companies.

Almost only Russian citizens serve as general directors in RBC 500 companies, the share of foreigners in the first positions does not exceed the statistical error (2.5%).

The rating includes 23 companies operating in the pharmaceutical market, 10 of them are pharmaceutical distributors.

PlaceCompany

Headquarters

Specialization

Revenue

Profit

57.

"Quatrain"

Khimki

Pharmaceutical distribution

169 billion rubles + 18%

3 billion rubles + 51% 58.

GC "Protek"

Moscow

Pharmaceutical distribution

157 billion rubles + 13% 5 billion rubles + 138% 

98.

SIA International Ltd.

Moscow

Pharmaceutical distribution

98 billion rubles + 31% 0.144 billion rubles- 42% 

123.

"Growth"

Moscow

Pharmaceutical distribution

73 billion rubles + 11% 0.396 billion rubles + 18% 

164.

R-Pharm

Moscow

Pharmaceutical distribution

56 billion rubles + 21% 8 billion rubles + 7% 

166.

FC "Pulse"

Khimki

Pharmaceutical distribution

55 billion rubles + 45% 0.588 billion rubles + 86% 

217.

Pharmstandard

Dolgoprudny

Pharmaceuticals

41 billion rubles - 28% 11 billion rubles - 7%

312.

"Farmcomplete"

Nizhniy Novgorod

Pharmaceutical distribution

28 billion rubles + 24% 0.012 billion rubles - 52% 

352.

"Abbott"

Moscow

Pharmaceuticals

24 billion rubles + 17% 3 billion rubles . 

353.

A5 Group of Companies

Moscow

Pharmaceuticals

24 billion rubles + 27% 384.

 

"Pharmacy chain 36,6"

Moscow

Pharmaceuticals

21 billion rubles . 385.

 

Nizhpharm

Nizhniy Novgorod

Pharmaceutical industry

21 billion rubles + 13% 1 billion rubles - 40% 

393.

"Pharmperspektiva"

Samara

Pharmaceutical distribution

21 billion rubles + 19% 0.174 billion rubles + 14% 

423.

Farmimex

Moscow

Pharmaceutical distribution

19 billion rubles + 33% 0.051 billion rubles - 15% 

426.

"Sandoz"

Moscow

Pharmaceuticals

19 billion rubles + 8% -0.312 billion rubles . 

MSD Pharmaceuticals

 

Moscow

Pharmaceuticals

19 billion rubles + 5%

1 billion +248%

460.

Euroservice Company

Fork

Pharmaceutical distribution

17 billion rubles + 26% 0.744 billion rubles + 30% 

466.

Beringer Ingelpharm

Moscow

Pharmaceuticals

17 billion rubles + 6% 0.016 billion rubles - 97% 

469.

Otisipharm

Moscow

Pharmaceuticals

17 billion rubles. 4 billion rubles. 

470.

Astrazeneca Pharmaceuticals

Moscow

Pharmaceuticals

17 billion rubles + 6% 0.010 billion rubles - 97% 

481.

Erkafarm

Moscow

Pharmaceuticals

16 billion rubles + 229% 0.583 billion rubles .

+ 1 172% 483.

"Servier"

Moscow

Pharmaceuticals

16 billion rubles + 7% 0.951 billion rubles + 57% 

492.

Krka Pharma

Istra

Pharmaceuticals

15 billion rubles + 5% 0.131 billion rubles - 47% 

Portal "Eternal youth" http://vechnayamolodost.ru


25.09.2015
Found a typo? Select it and press ctrl + enter Print version